Amanda K. Hall

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

The Digital Health Divide

Amanda K. Hall, Jay M. Bernhardt, Virginia J. Dodd et al. · Health Education & Behavior · 2014 · 192 citations · Full text

Social marketing at the right place and right time with new media

Jay M. Bernhardt, Darren Mays, Amanda K. Hall · Journal of Social Marketing · 2012 · 75 citations

Right Place, Digital Marketing, Emerging Media +23

Acceptance and perceived usefulness of robots to assist with activities of daily living and healthcare tasks

Amanda K. Hall, Uba Backonja, Ian Painter et al. · Assistive Technology · 2017 · 72 citations